Know Cancer

or
forgot password
  • cancer clinical trials in la porte, IN

  • Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer, Psychosocial Effects of Cancer and Its Treatment
    Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lymphoma
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lymphoma
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lung Cancer
    Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Esophageal Cancer, Gastric Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Endometrial Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Lymphoma
    Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Metastatic Cancer, Prostate Cancer
    Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
    Michiana Hematology Oncology PC - La Porte
    La Porte, Indiana 46350
    Cervical Cancer, Precancerous Condition
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Prostate Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Colorectal Cancer
    Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Colorectal Cancer
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Lung Cancer, Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Metastatic Cancer, Prostate Cancer
    Octreotide in Treating Patients With Cancer-Related Malignant Ascites
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Fallopian Tube Cancer, Ovarian Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Colorectal Cancer
    Quality of Life in Female Breast Cancer Survivors and Their Spouse, Partner, or Acquaintance
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Psychosocial Effects of Cancer and Its Treatment, Sexuality and Reproductive Issues, Spiritual Concerns
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Prostate Cancer
    Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Esophageal Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Esophageal Cancer
    S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells in Women With Metastatic Breast Cancer Receiving Chemotherapy
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    La Porte, Indiana 46350
    Breast Cancer
    Using the Internet to Collect Symptoms and the Ability to Carry Out Daily Activities From Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Prostate Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Ovarian Cancer
    Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
    Michiana Hematology Oncology PC - La Porte
    La Porte, Indiana 46350
    Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
    Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy
    Indiana University Health La Porte Hospital
    La Porte, Indiana 46350
    Recurrent Colon Cancer, Recurrent Rectal Cancer, Stage IVA Colon Cancer, Stage IVA Rectal Cancer, Stage IVB Colon Cancer, Stage IVB Rectal Cancer
    Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia
    Center for Cancer Therapy at LaPorte Hospital and Health Services

    Trial Locations
    Center for Cancer Therapy at LaPorte Hospital and Health Services
    Michiana Hematology Oncology PC - La Porte
    Endometrial Cancer, Precancerous Condition